Cargando…

Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling

Prostate cancer (PCa) has become a leading cause of cancer-associated incidence and mortality in men worldwide. However, most primary PCas relapse to castration-resistant PCa (CRPC) after androgen deprivation treatment. The current treatment for CRPC is based on chemotherapeutic drugs such as doceta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Jianchao, Wang, Pengyu, Ma, Hangbin, Zhang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930254/ https://www.ncbi.nlm.nih.gov/pubmed/35310915 http://dx.doi.org/10.1155/2022/9055954

Ejemplares similares

Targeting eIF3f Suppresses the Growth of Prostate Cancer Cells by Inhibiting Akt Signaling
por: Li, Junhong, et al.
Publicado: (2020)

DDX52 knockdown inhibits the growth of prostate cancer cells by regulating c-Myc signaling
por: Yu, Wandong, et al.
Publicado: (2021)

Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway
por: Fu, Runjia, et al.
Publicado: (2019)

Solamargine induces autophagy‐mediated apoptosis and enhances bortezomib activity in multiple myeloma
por: Han, Qiaoyan, et al.
Publicado: (2022)

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
por: Ge, Jianchao, et al.
Publicado: (2021)

Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer
por: Ma, Hangbin, et al.
Publicado: (2023)

Fe(3)O(4)-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells
por: Xie, Xiaodong, et al.
Publicado: (2018)

Solamargine induces hepatocellular carcinoma cell apoptosis and autophagy via inhibiting LIF/miR-192-5p/CYR61/Akt signaling pathways and eliciting immunostimulatory tumor microenvironment
por: Yin, Shuangshuang, et al.
Publicado: (2022)

Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel
por: Wang, Huming, et al.
Publicado: (2023)

Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway
por: Singh, Santosh Kumar, et al.
Publicado: (2019)

Solamargine Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma by Decreasing LncRNA HOXA11-As Expression
por: Meng, Ying, et al.
Publicado: (2022)

Solamargine induces apoptosis of human renal carcinoma cells via downregulating phosphorylated STAT3 expression
por: Huang, Shuaishuai, et al.
Publicado: (2023)

Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway
por: Tang, Qing, et al.
Publicado: (2022)

Solamargine inhibits proliferation and promotes apoptosis of CM-319 human chordoma cells through suppression of notch pathway
por: Liu, Junqi, et al.
Publicado: (2019)

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells
por: Vakhrusheva, Olesya, et al.
Publicado: (2022)

Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
por: Lim, Hyun-Kyung, et al.
Publicado: (2016)

Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells
por: Xiang, SongTao, et al.
Publicado: (2016)

Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways
por: Lu, Xinxing, et al.
Publicado: (2020)

Combination Modality Using Quercetin to Enhance the Efficacy of Docetaxel in Prostate Cancer Cells
por: Sharma, Satish, et al.
Publicado: (2023)

Solamargine Alleviates Proliferation and Metastasis of Cervical Cancer Cells by Blocking the CXCL3-Mediated Erk Signaling Pathway
por: Qu, Xiangdong, et al.
Publicado: (2022)

Solamargine, a bioactive steroidal alkaloid isolated from Solanum aculeastrum induces non-selective cytotoxicity and P-glycoprotein inhibition
por: Burger, Trevor, et al.
Publicado: (2018)

Solamargine derived from Solanum nigrum induces apoptosis of human cholangiocarcinoma QBC939 cells
por: Zhang, Xiuhua, et al.
Publicado: (2018)

Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
por: Han, Yi, et al.
Publicado: (2022)

Polyunsaturated fatty acid-based targeted nanotherapeutics to enhance the therapeutic efficacy of docetaxel
por: Ramasamy, Thiruganesh, et al.
Publicado: (2017)

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
por: Brubaker, Kristen D, et al.
Publicado: (2006)

CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer
por: Chen, Binshen, et al.
Publicado: (2020)

Guggulsterone inhibits prostate cancer growth via inactivation of Akt regulated by ATP citrate lyase signaling
por: Gao, Yajuan, et al.
Publicado: (2015)

Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer
por: Mout, Lisanne, et al.
Publicado: (2020)

Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells
por: Chen, YuQing, et al.
Publicado: (2015)

Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative
por: Zhang, Shumin, et al.
Publicado: (2016)

Targeting EP4 downstream c‐Jun through ERK1/2‐mediated reduction of DNMT1 reveals novel mechanism of solamargine‐inhibited growth of lung cancer cells
por: Chen, Yuqing, et al.
Publicado: (2016)

Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer
por: Mimeault, Murielle, et al.
Publicado: (2015)

Solamargine Alleviated UVB-Induced Inflammation and Melanogenesis in Human Keratinocytes and Melanocytes via the p38 MAPK Signaling Pathway, a Promising Agent for Post-inflammatory Hyperpigmentation
por: Zhao, Juemin, et al.
Publicado: (2022)

Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer
por: Niu, Xiao-Bing, et al.
Publicado: (2017)

Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone
por: Kirk, Peter S., et al.
Publicado: (2013)

MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling
por: Yan, Guang, et al.
Publicado: (2019)

Versican is a potential therapeutic target in docetaxel-resistant prostate cancer
por: Arichi, Naoko, et al.
Publicado: (2015)

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel
por: Uzoh, C C, et al.
Publicado: (2011)

Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells
por: Wang, Lei, et al.
Publicado: (2020)

Correction to: MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling
por: Yan, Guang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cbb1dnh5utuh2ffc1rhmef9n97